Toxin models of mitochondrial dysfunction in Parkinson's disease

Antioxidants and Redox Signaling

Volumn 16, Issue 9, 2012, Pages 920-934

  Martinez, Terina N ^a   Greenamyre, J Timothy ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MANCOZEB; MANEB; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; NEUROTOXIN; NEUROTRANSMITTER; OXIDOPAMINE; PARAQUAT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); ROTENONE; SUPEROXIDE DISMUTASE; TRICHLOROETHYLENE; ZINEB;

APOPTOSIS; BLOOD BRAIN BARRIER; CALCIUM CELL LEVEL; CLINICAL EVALUATION; DISEASE ASSOCIATION; DOPAMINERGIC NERVE CELL; ENVIRONMENTAL EXPOSURE; EXCITOTOXICITY; HUMAN; INTRACELLULAR SIGNALING; LEWY BODY; MEMBRANE DEPOLARIZATION; MITOCHONDRIAL DNA DISORDER; MITOCHONDRIAL ENERGY TRANSFER; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; MITOCHONDRIAL TOXICITY; NERVE CELL NECROSIS; NEUROMODULATION; NEUROPATHOLOGY; NEUROPROTECTION; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SUBSTANTIA NIGRA PARS COMPACTA;

ANIMALS; DISEASE MODELS, ANIMAL; DOPAMINERGIC NEURONS; HUMANS; MITOCHONDRIA; PARKINSON DISEASE, SECONDARY; TOXINS, BIOLOGICAL;

ANIMALIA;

EID: 84857981316     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2011.4033     Document Type: Review

References (124)

1. Ahmadi FA, Linseman DA, Grammatopoulos TN, Jones SM, Bouchard RJ, Freed CR, Heidenreich KA, and Zawada WM. The pesticide rotenone induces caspase-3-mediated apoptosis in ventral mesencephalic dopaminergic neurons. J Neurochem 87: 914-921, 2003. (Pubitemid 37444567)
2. Anderson G, Noorian AR, Taylor G, Anitha M, Bernhard D, Srinivasan S, and Greene JG. Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's disease. Exp Neurol 207: 4-12, 2007. (Pubitemid 47332479)
3. Arnold B, Cassady SJ, VanLaar VS, and Berman SB. Integrating multiple aspects of mitochondrial dynamics in neurons: Age-related differences and dynamic changes in a chronic rotenone model. Neurobiol Dis 41: 189-200, 2011.
4. Ascherio A, Chen H, Weisskopf MG, O'Reilly E, McCullough ML, Calle EE, Schwarzschild MA, and Thun MJ. Pesticide exposure and risk for Parkinson's disease. Ann Neurol 60: 197-203, 2006. (Pubitemid 44182394)
5. Barrot M, Calza L, Pozza M, Le Moal M, and Piazza PV. Differential calbindin-immunoreactivity in dopamine neurons projecting to the rat striatal complex. Eur J Neurosci 12: 4578-4582, 2000. (Pubitemid 32037869)
6. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, and Greenamyre JT. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 3: 1301-1306, 2000.
7. Bove J, Prou D, Perier C, and Przedborski S. Toxin-induced models of Parkinson's disease. NeuroRx 2: 484-494, 2005. (Pubitemid 41444882)
8. Braak H, Ghebremedhin E, Rub U, Bratzke H, and Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 318: 121-134, 2004. (Pubitemid 39362633)
9. Brooks AI, Chadwick CA, Gelbard HA, Cory-Slechta DA, and Federoff HJ. Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss. Brain Res 823: 1-10, 1999. (Pubitemid 29225488)
10. Brown TP, Rumsby PC, Capleton AC, Rushton L, and Levy LS. Pesticides and Parkinson's disease-Is there a link? Environ Health Perspect 114: 156-164, 2006. (Pubitemid 43193633)
11. Bueler H. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease. Exp Neurol 218: 235-246, 2009.
12. Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, and Kopin IJ. A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6- tetrahydropyridine. Proc Natl Acad Sci USA 80: 4546-4550, 1983. (Pubitemid 13077876)
13. Cannon JR, Tapias V, Na HM, Honick AS, Drolet RE, and Greenamyre JT. A highly reproducible rotenone model of Parkinson's disease. Neurobiol Dis 34: 279-290, 2009.
14. Castello PR, Drechsel DA, and Patel M. Mitochondria are a major source of paraquat-induced reactive oxygen species production in the brain. J Biol Chem 282: 14186-14193, 2007. (Pubitemid 47100444)
15. Cerruti C, Walther DM, Kuhar MJ, and Uhl GR. Dopamine transporter mRNA expression is intense in rat midbrain neurons and modest outside midbrain. Brain Res Mol Brain Res 18: 181-186, 1993.
16. Chan CS, Guzman JN, Ilijic E, Mercer JN, Rick C, Tkatch T, Meredith GE, and Surmeier DJ. 'Rejuvenation' protects neurons in mouse models of Parkinson's disease. Nature 447: 1081-1086, 2007. (Pubitemid 47014425)
17. Chan P, DeLanney LE, Irwin I, Langston JW, and Di Monte D. Rapid ATP loss caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse brain. J Neurochem 57: 348-351, 1991.
18. Chaturvedi RK and Beal MF. Mitochondrial approaches for neuroprotection. Ann NY Acad Sci 1147: 395-412, 2008.
19. Chiba K, Trevor A, and Castagnoli N, Jr. Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. Biochem Biophys Res Commun 120: 574-578, 1984. (Pubitemid 14101750)
20. Cicchetti F, Drouin-Ouellet J, and Gross RE. Environmental toxins and Parkinson's disease: What have we learned from pesticide-induced animal models? Trends Pharmacol Sci 30: 475-483, 2009.
21. Cocheme HM and Murphy MP. Complex I is the major site of mitochondrial superoxide production by paraquat. J Biol Chem 283: 1786-1798, 2008.
22. Corasaniti MT, Defilippo R, Rodino P, Nappi G, and Nistico G. Evidence that paraquat is able to cross the bloodbrain barrier to a different extent in rats of various age. Funct Neurol 6: 385-391, 1991.
23. Corasaniti MT, Strongoli MC, Rotiroti D, Bagetta G, and Nistico G. Paraquat: A useful tool for the in vivo study of mechanisms of neuronal cell death. Pharmacol Toxicol 83: 1-7, 1998. (Pubitemid 28386891)
24. Costello S, Cockburn M, Bronstein J, Zhang X, and Ritz B. Parkinson's disease and residential exposure to maneb and paraquat from agricultural applications in the central valley of California. Am J Epidemiol 169: 919-926, 2009.
25. Davey GP and Clark JB. Threshold effects and control of oxidative phosphorylation in nonsynaptic rat brain mitochondria. J Neurochem 66: 1617-1624, 1996. (Pubitemid 26090563)
26. Davey GP, Tipton KF, and Murphy MP. Uptake and accumulation of 1-methyl-4-phenylpyridinium by rat liver mitochondria measured using an ion-selective electrode. Biochem J 288: 439-443, 1992.
27. Dehmer T, Lindenau J, Haid S, Dichgans J, and Schulz JB. Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo. J Neurochem 74: 2213-2216, 2000. (Pubitemid 30217680)
28. Desai VG, Feuers RJ, Hart RW, and Ali SF. MPP( + )-induced neurotoxicity in mouse is age-dependent: Evidenced by the selective inhibition of complexes of electron transport. Brain Res 715: 1-8, 1996. (Pubitemid 26141647)
29. Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, and Tanner CM. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 68: 384-386, 2007. (Pubitemid 46184217)
30. Drechsel DA and Patel M. Differential contribution of the mitochondrial respiratory chain complexes to reactive oxygen species production by redox cycling agents implicated in parkinsonism. Toxicol Sci 112: 427-434, 2009.
31. Drolet RE, Cannon JR, Montero L, and Greenamyre JT. Chronic rotenone exposure reproduces Parkinson's disease gastrointestinal neuropathology. Neurobiol Dis 36: 96-102, 2009.
32. Dunnett SB and Bjorklund A. Prospects for new restorative and neuroprotective treatments in Parkinson's disease. Nature 399: A32-39, 1999.
33. Fei Q and Ethell DW. Maneb potentiates paraquat neurotoxicity by inducing key Bcl-2 family members. J Neurochem 105: 2091-2097, 2008. (Pubitemid 351782244)
34. Fornai F, Schluter OM, Lenzi P, Gesi M, Ruffoli R, Ferrucci M, Lazzeri G, Busceti CL, Pontarelli F, Battaglia G, Pellegrini A, Nicoletti F, Ruggieri S, Paparelli A, and Sudhof TC. Parkinson-like syndrome induced by continuous MPTP infusion: Convergent roles of the ubiquitin-proteasome system and alpha-synuclein. Proc Natl Acad Sci USA 102: 3413-3418, 2005. (Pubitemid 40328059)
35. Fox SH, Brotchie JM, and Lang AE. Non-dopaminergic treatments in development for Parkinson's disease. Lancet Neurol 7: 927-938, 2008.
36. Gainetdinov RR, Fumagalli F, Jones SR, and Caron MG. Dopamine transporter is required for in vivo MPTP neurotoxicity: Evidence from mice lacking the transporter. J Neurochem 69: 1322-1325, 1997. (Pubitemid 27364858)
37. Gash DM, Rutland K, Hudson NL, Sullivan PG, Bing G, Cass WA, Pandya JD, Liu M, Choi DY, Hunter RL, Gerhardt GA, Smith CD, Slevin JT, and Prince TS. Trichloroethylene: Parkinsonism and complex 1 mitochondrial neurotoxicity. Ann Neurol 63: 184-192, 2008. (Pubitemid 351355297)
38. Gomez-Lazaro M, Bonekamp NA, Galindo MF, Jordan J, and Schrader M. 6-Hydroxydopamine (6-OHDA) induces Drp1-dependent mitochondrial fragmentation in SH-SY5Y cells. Free Radic Biol Med 44: 1960-1969, 2008.
39. Gomez C, Bandez MJ, and Navarro A. Pesticides and impairment of mitochondrial function in relation with the parkinsonian syndrome. Front Biosci 12: 1079-1093, 2007. (Pubitemid 46846880)
40. Greenamyre JT, Betarbet R, and Sherer TB. The rotenone model of Parkinson's disease: Genes, environment and mitochondria. Parkinsonism Relat Disord 9: S59-64, 2003.
41. Greenamyre JT, Sherer TB, Betarbet R, and Panov AV. Complex I and Parkinson's disease. IUBMB Life 52: 135-141, 2001. (Pubitemid 33731566)
42. Hatefi Y. The mitochondrial electron transport and oxidative phosphorylation system. Annu Rev Biochem 54: 1015-1069, 1985. (Pubitemid 15073670)
43. Hattori N, Tanaka M, Ozawa T, and Mizuno Y. Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease. Ann Neurol 30: 563-571, 1991.
44. Heikkila RE, Hess A, and Duvoisin RC. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice. Science 224: 1451-1453, 1984. (Pubitemid 14123348)
45. Heikkila RE, Nicklas WJ, Vyas I, and Duvoisin RC. Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: Implication for the mechanism of 1-methyl-4-phenyl-1,2, 3,6-tetrahydropyridine toxicity. Neurosci Lett 62: 389-394, 1985. (Pubitemid 16147750)
46. Hollerhage M, Matusch A, Champy P, Lombes A, Ruberg M, Oertel WH, and Hoglinger GU. Natural lipophilic inhibitors of mitochondrial complex I are candidate toxins for sporadic neurodegenerative tau pathologies. Exp Neurol 220: 133-142, 2009.
47. Inden M, Kitamura Y, Abe M, Tamaki A, Takata K, and Taniguchi T. Parkinsonian rotenone mouse model: Reevaluation of long-term administration of rotenone in C57BL/6 mice. Biol Pharm Bull 34: 92-96, 2011.
48. Jackson-Lewis V, Jakowec M, Burke RE, and Przedborski S. Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurodegeneration 4: 257-269, 1995.
49. Jenner P. Molecular mechanisms of L-DOPA-induced dyskinesia. Nat Rev Neurosci 9: 665-677, 2008.
50. Jenner P. From the MPTP-treated primate to the treatment of motor complications in Parkinson's disease. Parkinsonism Relat Disord 15: S18-23, 2009.
51. Jones GM and Vale JA. Mechanisms of toxicity, clinical features, and management of diquat poisoning: A review. J Toxicol Clin Toxicol 38: 123-128, 2000. (Pubitemid 30212833)
52. Kilbride SM, Telford JE, Tipton KF, and Davey GP. Partial inhibition of complex I activity increases Ca-independent glutamate release rates from depolarized synaptosomes. J Neurochem 106: 826-834, 2008.
53. Klaidman LK, Adams JD, Jr., Leung AC, Kim SS, and Cadenas E. Redox cycling of MPP+ : Evidence for a new mechanism involving hydride transfer with xanthine oxidase, aldehyde dehydrogenase, and lipoamide dehydrogenase. Free Radic Biol Med 15: 169-179, 1993. (Pubitemid 23218819)
54. Langston JW, Ballard P, Tetrud JW, and Irwin I. Chronic Parkinsonism in humans due to a product of meperidineanalog synthesis. Science 219: 979-980, 1983. (Pubitemid 13189531)
55. Langston JW, Forno LS, Tetrud J, Reeves AG, Kaplan JA, and Karluk D. Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Ann Neurol 46: 598-605, 1999. (Pubitemid 29466438)
56. Le Couteur DG, McLean AJ, Taylor MC, Woodham BL, and Board PG. Pesticides and Parkinson's disease. Biomed Pharmacother 53: 122-130, 1999. (Pubitemid 29507874)
57. Lebouvier T, Neunlist M, Bruley des Varannes S, Coron E, Drouard A, N'Guyen JM, Chaumette T, Tasselli M, Paillusson S, Flamand M, Galmiche JP, Damier P, and Derkinderen P. Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms. PLoS One 5: e12728, 2010.
58. Levy BS and Nassetta WJ. Neurologic effects of manganese in humans: A review. Int J Occup Environ Health 9: 153-163, 2003. (Pubitemid 44783341)
59. Lin MT and Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443: 787-795, 2006. (Pubitemid 44622683)
60. Liu M, Choi DY, Hunter RL, Pandya JD, Cass WA, Sullivan PG, Kim HC, Gash DM, and Bing G. Trichloroethylene induces dopaminergic neurodegeneration in Fisher 344 rats. J Neurochem 112: 773-783, 2010.
61. Liu Y, Roghani A, and Edwards RH. Gene transfer of a reserpine-sensitive mechanism of resistance to N-methyl-4-phenylpyridinium. Proc Natl Acad SciUSA 89: 9074-9078, 1992.
62. Manning-Bog AB, McCormack AL, Li J, Uversky VN, Fink AL, and Di Monte DA. The herbicide paraquat causes upregulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein. J Biol Chem 277: 1641-1644, 2002. (Pubitemid 34968732)
63. McCormack AL and Di Monte DA. Effects of L-dopa and other amino acids against paraquat-induced nigrostriatal degeneration. J Neurochem 85: 82-86, 2003. (Pubitemid 36389697)
64. McCormack AL, Thiruchelvam M, Manning-Bog AB, Thiffault C, Langston JW, Cory-Slechta DA, and Di Monte DA. Environmental risk factors and Parkinson's disease: Selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiol Dis 10: 119-127, 2002. (Pubitemid 34775465)
65. McGrew DM, Irwin I, and Langston JW. Ethylenebisdithiocarbamate enhances MPTP-induced striatal dopamine depletion in mice. Neurotoxicology 21: 309-312, 2000. (Pubitemid 30436429)
66. Meco G, Bonifati V, Vanacore N, and Fabrizio E. Parkinsonism after chronic exposure to the fungicide maneb (manganese ethylene-bis-dithiocarbamate) . Scand J Work Environ Health 20: 301-305, 1994. (Pubitemid 24291313)
67. Misiak M, Beyer C, and Arnold S. Gender-specific role of mitochondria in the vulnerability of 6-hydroxydopaminetreated mesencephalic neurons. Biochim Biophys Acta 1797: 1178-1188, 2010.
68. Mollace V, Iannone M, Muscoli C, Palma E, Granato T, Rispoli V, Nistico R, Rotiroti D, and Salvemini D. The role of oxidative stress in paraquat-induced neurotoxicity in rats: Protection by non peptidyl superoxide dismutase mimetic. Neurosci Lett 335: 163-166, 2003. (Pubitemid 36071625)
69. Morato GS, Lemos T, and Takahashi RN. Acute exposure to maneb alters some behavioral functions in the mouse. Neurotoxicol Teratol 11: 421-425, 1989. (Pubitemid 20043107)
70. Natale G, Kastsiushenka O, Fulceri F, Ruggieri S, Paparelli A, and Fornai F. MPTP-induced parkinsonism extends to a subclass of TH-positive neurons in the gut. Brain Res 1355: 195-206, 2010.
71. Nicholls DG. Oxidative stress and energy crises in neuronal dysfunction. Ann NY Acad Sci 1147: 53-60, 2008.
72. Nicklas WJ, Vyas I, and Heikkila RE. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Life Sci 36: 2503-2508, 1985. (Pubitemid 15072756)
73. Nunomura A, Honda K, Takeda A, Hirai K, Zhu X, Smith MA, and Perry G. Oxidative damage to RNA in neurodegenerative diseases. J Biomed Biotechnol 2006: 82323, 2006.
74. Ossowska K, Wardas J, Smialowska M, Kuter K, Lenda T, Wieronska JM, Zieba B, Nowak P, Dabrowska J, Bortel A, Kwiecinski A, and Wolfarth S. A slowly developing dysfunction of dopaminergic nigrostriatal neurons induced by long-term paraquat administration in rats: An animal model of preclinical stages of Parkinson's disease? Eur J Neurosci 22: 1294-1304, 2005. (Pubitemid 41442403)
75. Petit-Paitel A, Brau F, Cazareth J, and Chabry J. Involvment of cytosolic and mitochondrial GSK-3beta in mitochondrial dysfunction and neuronal cell death of MPTP/MPP-treated neurons. PLoS One 4: e5491, 2009.
76. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, and Nussbaum RL. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276: 2045-2047, 1997. (Pubitemid 27443610)
77. Prasad K, Winnik B, Thiruchelvam MJ, Buckley B, Mirochnitchenko O, and Richfield EK. Prolonged toxicokinetics and toxicodynamics of paraquat in mouse brain. Environ Health Perspect 115: 1448-1453, 2007. (Pubitemid 47628332)
78. Przedborski S, Kostic V, Jackson-Lewis V, Naini AB, Simonetti S, Fahn S, Carlson E, Epstein CJ, and Cadet JL. Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced neurotoxicity. J Neurosci 12: 1658-1667, 1992.
79. Przedborski S and Vila M. The 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine mouse model: A tool to explore the pathogenesis of Parkinson's disease. Ann NY Acad Sci 991: 189-198, 2003. (Pubitemid 36793814)
80. Ramsay RR and Singer TP. Energy-dependent uptake of N-methyl-4- phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine, by mitochondria. J Biol Chem 261: 7585-7587, 1986. (Pubitemid 17208669)
81. Ravanel P, Tissut M, and Douce R. Effects of rotenoids on isolated plant mitochondria. Plant Physiol 75: 414-420, 1984.
82. Richardson JR, Quan Y, Sherer TB, Greenamyre JT, and Miller GW. Paraquat neurotoxicity is distinct from that of MPTP and rotenone. Toxicol Sci 88: 193-201, 2005. (Pubitemid 41548761)
83. Rojo AI, Montero C, Salazar M, Close RM, Fernandez-Ruiz J, Sanchez-Gonzalez MA, de Sagarra MR, Jackson-Lewis V, Cavada C, and Cuadrado A. Persistent penetration of MPTP through the nasal route induces Parkinson's disease in mice. Eur J Neurosci 24: 1874-1884, 2006. (Pubitemid 44583472)
84. Rossetti ZL, Sotgiu A, Sharp DE, Hadjiconstantinou M, and Neff NH. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and free radicals in vitro. Biochem Pharmacol 37: 4573-4574, 1988. (Pubitemid 19003818)
85. Schapira AH. Mitochondria in the aetiology and pathogenesis of Parkinson's disease. Lancet Neurol 7: 97-109, 2008. (Pubitemid 350251942)
86. Schapira AH, Cooper JM, Dexter D, Clark JB, Jenner P, and Marsden CD. Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 54: 823-827, 1990.
87. Schmidt N and Ferger B. Neurochemical findings in the MPTP model of Parkinson's disease. J Neural Transm 108: 1263-1282, 2001. (Pubitemid 33141302)
88. Schulz JB, Matthews RT, Muqit MM, Browne SE, and Beal MF. Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. J Neurochem 64: 936-939, 1995.
89. Sherer TB, Betarbet R, Testa CM, Seo BB, Richardson JR, Kim JH, Miller GW, Yagi T, Matsuno-Yagi A, and Greenamyre JT. Mechanism of toxicity in rotenone models of Parkinson's disease. J Neurosci 23: 10756-10764, 2003. (Pubitemid 37499681)
90. Sherer TB, Richardson JR, Testa CM, Seo BB, Panov AV, Yagi T, Matsuno-Yagi A, Miller GW, and Greenamyre JT. Mechanism of toxicity of pesticides acting at complex I: relevance to environmental etiologies of Parkinson's disease. J Neurochem 100: 1469-1479, 2007. (Pubitemid 46376213)
91. Shimizu K, Matsubara K, Ohtaki K, Fujimaru S, Saito O, and Shiono H. Paraquat induces long-lasting dopamine overflow through the excitotoxic pathway in the striatum of freely moving rats. Brain Res 976: 243-252, 2003. (Pubitemid 36570461)
92. Shimizu K, Matsubara K, Ohtaki K, and Shiono H. Paraquat leads to dopaminergic neural vulnerability in organotypic midbrain culture. Neurosci Res 46: 523-532, 2003. (Pubitemid 36842803)
93. Singh S, Kumar S, and Dikshit M. Involvement of the mitochondrial apoptotic pathway and nitric oxide synthase in dopaminergic neuronal death induced by 6-hydroxydopamine and lipopolysaccharide. Redox Rep 15: 115-122, 2010.
94. Sirinathsinghji DJ, Heavens RP, Richards SJ, Beresford IJ, and Hall MD. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway-I. Behavioural, neurochemical and histological characterization of the lesion. Neuroscience 27: 117-128, 1988.
95. Soleo L, Defazio G, Scarselli R, Zefferino R, Livrea P, and Foa V. Toxicity of fungicides containing ethylenebis-dithiocarbamate in serumless dissociated mesencephalic-striatal primary coculture. Arch Toxicol 70: 678-682, 1996. (Pubitemid 26258636)
96. Striessnig J, Koschak A, Sinnegger-Brauns MJ, Hetzenauer A, Nguyen NK, Busquet P, Pelster G, and Singewald N. Role of voltage-gated L-type Ca2 + channel isoforms for brain function. Biochem Soc Trans 34: 903-909, 2006. (Pubitemid 44796447)
97. Su B, Wang X, Zheng L, Perry G, Smith MA, and Zhu X. Abnormal mitochondrial dynamics and neurodegenerative diseases. Biochim Biophys Acta 1802: 135-142, 2010.
98. Surmeier DJ, Guzman JN, Sanchez-Padilla J, and Goldberg JA. The origins of oxidant stress in Parkinson's disease and therapeutic strategies. Antioxid Redox Signal 14: 1289-1301, 2011.
99. Swerdlow RH, Parks JK, Miller SW, Tuttle JB, Trimmer PA, Sheehan JP, Bennett JP, Jr., Davis RE, and Parker WD, Jr. Origin and functional consequences of the complex I defect in Parkinson's disease. Ann Neurol 40: 663-671, 1996. (Pubitemid 26357892)
100. Tada-Oikawa S, Hiraku Y, Kawanishi M, and Kawanishi S. Mechanism for generation of hydrogen peroxide and change of mitochondrial membrane potential during rotenone-induced apoptosis. Life Sci 73: 3277-3288, 2003. (Pubitemid 37237579)
101. Takahashi RN, Rogerio R, and Zanin M. Maneb enhances MPTP neurotoxicity in mice. Res Commun Chem Pathol Pharmacol 66: 167-170, 1989. (Pubitemid 19267344)
102. Tanner CM, Kamel F, Ross GW, Hoppin JA, Goldman SM, Korell M, Marras C, Bhudhikanok GS, Kasten M, Chade AR, Comyns K, Richards MB, Meng C, Priestley B, Fernandez HH, Cambi F, Umbach DM, Blair A, Sandler DP, and Langston JW. Rotenone, paraquat and Parkinson's disease. Environ Health Perspect 119:866-872, 2011.
103. Tapias V, Cannon JR, and Greenamyre JT. Melatonin treatment potentiates neurodegeneration in a rat rotenone Parkinson's disease model. J Neurosci Res 88: 420-427, 2010.
104. Tapias V, Escames G, Lopez LC, Lopez A, Camacho E, Carrion MD, Entrena A, Gallo MA, Espinosa A, and Acuna-Castroviejo D. Melatonin and its brain metabolite N(1)-acetyl-5-methoxykynuramine prevent mitochondrial nitric oxide synthase induction in parkinsonian mice. J Neurosci Res 87: 3002-3010, 2009.
105. TerziogluMandGalterD. Parkinson's disease: Genetic versus toxin-induced rodent models. FEBS J 275: 1384-1391, 2008.
106. Thiruchelvam M, Brockel BJ, Richfield EK, Baggs RB, and Cory-Slechta DA. Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: Environmental risk factors for Parkinson's disease? Brain Res 873: 225-234, 2000. (Pubitemid 30619046)
107. Thiruchelvam M, McCormack A, Richfield EK, Baggs RB, Tank AW, Di Monte DA, and Cory-Slechta DA. Age-related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype. Eur J Neurosci 18: 589-600, 2003. (Pubitemid 37045378)
108. Thiruchelvam M, Prokopenko O, Cory-Slechta DA, Buckley B, and Mirochnitchenko O. Overexpression of superoxide dismutase or glutathione peroxidase protects against the paraquat + maneb-induced Parkinson disease phenotype. J Biol Chem 280: 22530-22539, 2005. (Pubitemid 40827911)
109. Thiruchelvam M, Richfield EK, Baggs RB, Tank AW, and Cory-Slechta DA. The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: Implications for Parkinson's disease. J Neurosci 20: 9207-9214, 2000. (Pubitemid 32042923)
110. Thiruchelvam M, Richfield EK, Goodman BM, Baggs RB, and Cory-Slechta DA. Developmental exposure to the pesticides paraquat and maneb and the Parkinson's disease phenotype. Neurotoxicology 23: 621-633, 2002. (Pubitemid 36527682)
111. Uversky VN. Neurotoxicant-induced animal models of Parkinson's disease: Understanding the role of rotenone, maneb and paraquat in neurodegeneration. Cell Tissue Res 318: 225-241, 2004. (Pubitemid 39362642)
112. Van Remmen H, QiW, Sabia M, Freeman G, Estlack L, Yang H, Mao Guo Z, Huang TT, Strong R, Lee S, Epstein CJ, and Richardson A. Multiple deficiencies in antioxidant enzymes in mice result in a compound increase in sensitivity to oxidative stress. Free Radic Biol Med 36: 1625-1634, 2004. (Pubitemid 38746568)
113. Vermulst M, Bielas JH, Kujoth GC, Ladiges WC, Rabinovitch PS, Prolla TA, and Loeb LA. Mitochondrial point mutations do not limit the natural lifespan of mice. Nat Genet 39: 540-543, 2007. (Pubitemid 46514771)
114. Werth JL and Thayer SA. Mitochondria buffer physiological calcium loads in cultured rat dorsal root ganglion neurons. J Neurosci 14: 348-356, 1994. (Pubitemid 24022122)
115. Xie W, Wan OW, and Chung KK. New insights into the role of mitochondrial dysfunction and protein aggregation in Parkinson's disease. Biochim Biophys Acta 1802: 935-941, 2010.
116. Yadava N and Nicholls DG. Spare respiratory capacity rather than oxidative stress regulates glutamate excitotoxicity after partial respiratory inhibition of mitochondrial complex I with rotenone. J Neurosci 27: 7310-7317, 2007. (Pubitemid 47037569)
117. Yang W and Tiffany-Castiglioni E. The bipyridyl herbicide paraquat produces oxidative stress-mediated toxicity in human neuroblastoma SH-SY5Y cells: Relevance to the dopaminergic pathogenesis. J Toxicol Environ Health A 68: 1939-1961, 2005. (Pubitemid 41765788)
118. Yao Z and Wood NW. Cell death pathways in Parkinson's disease: Role of mitochondria. Antioxid Redox Signal 11: 2135-2149, 2009.
119. Yazdani U, German DC, Liang CL, Manzino L, Sonsalla PK, and Zeevalk GD. Rat model of Parkinson's disease: Chronic central delivery of 1-methyl-4-phenylpyridinium (MPP+ ). Exp Neurol 200: 172-183, 2006. (Pubitemid 44080759)
120. Yumino K, Kawakami I, Tamura M, Hayashi T, and Nakamura M. Paraquat-and diquat-induced oxygen radical generation and lipid peroxidation in rat brain microsomes. J Biochem 131: 565-570, 2002. (Pubitemid 34456612)
121. Zhang J, Fitsanakis VA, Gu G, Jing D, AoM, Amarnath V, and Montine TJ. Manganese ethylene-bis-dithiocarbamate and selective dopaminergic neurodegeneration in rat: A link through mitochondrial dysfunction. J Neurochem 84: 336-346, 2003. (Pubitemid 36182275)
122. Zhang J, Graham DG, Montine TJ, and Ho YS. Enhanced Nmethyl-4-phenyl-1,2, 3,6-tetrahydropyridine toxicity in mice deficient in CuZn-superoxide dismutase or glutathione peroxidase. J Neuropathol Exp Neurol 59: 53-61, 2000. (Pubitemid 30069225)
123. Zhang X, Zhou JY, Chin MH, Schepmoes AA, Petyuk VA, Weitz KK, Petritis BO, Monroe ME, Camp DG, Wood SA, Melega WP, Bigelow DJ, Smith DJ, Qian WJ, and Smith RD. Region-specific protein abundance changes in the brain of MPTP-induced Parkinson's disease mouse model. J Proteome Res 9: 1496-1509, 2010.
124. Zhou Y, Shie FS, Piccardo P, Montine TJ, and Zhang J. Proteasomal inhibition induced by manganese ethylenebis-dithiocarbamate: Relevance to Parkinson's disease. Neuroscience 128: 281-291, 2004. (Pubitemid 39200476)